- Home
- KZIA vs MRDN Comparison
KZIA vs MRDN Comparison
Compare KZIA & MRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZIA | MRDN |
|---|---|---|
| Founded | 1994 | N/A |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.7M | 155.1M |
| IPO Year | 2002 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KZIA | MRDN |
|---|---|---|
| Price | $9.33 | $11.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $28.36 | $19.73 |
| AVG Volume (30 Days) | ★ 277.0K | 50.1K |
| Earning Date | 11-06-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | ★ $182,863,373.00 |
| Revenue This Year | N/A | $12.08 |
| Revenue Next Year | N/A | $10.93 |
| P/E Ratio | ★ N/A | $31.74 |
| Revenue Growth | N/A | ★ 21.01 |
| 52 Week Low | $4.86 | $6.01 |
| 52 Week High | $17.40 | $16.09 |
Technical Indicators
Market Signals| Indicator | KZIA | MRDN |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 28.89 |
| Support Level | $9.01 | $9.99 |
| Resistance Level | $14.85 | $14.76 |
| Average True Range (ATR) | 0.65 | 0.58 |
| MACD | -0.01 | -0.25 |
| Stochastic Oscillator | 12.48 | 7.32 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About MRDN Meridian Holdings Inc. Common Stock
Meridian Holdings Inc is engaged in the online gaming and betting business, providing sports betting, online casino, and gaming operations across multiple jurisdictions in Europe, Africa, and Central and South America. The company has three reportable segments: MeridianBet Group, GMAG, and RKings & CFAC. The MeridianBet Group segment includes retail and online sports betting, casinos, and related gaming operations. The GMAG segment focuses on the resale of third-party gaming content, mainly serving customers in the Asia-Pacific region. The RKings & CFAC segment is involved in pay-to-enter prize competitions and trade promotions conducted in the United Kingdom and Australia. It generates the majority of its revenue from the MeridianBet Group segment.